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We describe the results of a genome-wide
analysis of human cells that suggests that
most protein-coding genes, including most
genes thought to be transcriptionally inactive,
experience transcription initiation. We found
that nucleosomes with H3K4me3 and
H3K9,14Ac modifications, together with RNA
polymerase II, occupy the promoters of most
protein-coding genes in human embryonic
stem cells. Only a subset of these genes
produce detectable full-length transcripts and
are occupied by nucleosomes with H3K36me3
modifications, a hallmark of elongation. The
other genes experience transcription initiation
but show no evidence of elongation, suggesting
that they are predominantly regulated at post-
initiation steps. Genes encoding most devel-
opmental regulators fall into this group. Our
results also identify a class of genes that are
excluded from experiencing transcription initia-
tion, at which mechanisms that prevent initia-
tion must predominate. These observations
extend to differentiated cells, suggesting that
transcription initiationatmost genes is ageneral
phenomenon in human cells.
INTRODUCTION
Studies of individual genes have revealed that transcrip-
tional regulation can occur at many levels, but these
regulatory mechanisms fall into two general models
(Ptashne, 1986; Krumm et al., 1993; Kuras and Struhl,
1999; Saunders et al., 2006). In one model, transcription
is regulated primarily at the initiation step, when DNA-
binding transcription factors recruit the transcriptional
machinery. In the other, the key regulatory mechanisms
occur subsequent to initiation and involve transcriptelongation or stability. These models are not mutually
exclusive but make different predictions about the chro-
matin state of the genome, which can be influenced by
transcription.
Transcription initiation and elongation are both associ-
ated with specific chemical modifications of the histone
components of nucleosomes that reside in the promoter
regions and transcribed portions of active protein-cod-
ing genes (Jenuwein and Allis, 2001; Turner, 2002; Sims
et al., 2004). Among the modifications associated with
transcription initiation, the histone H3 lysine 4 trimethyl
(H3K4me3) mark occurs in nucleosomes found in the
promoter regions of actively transcribed genes (Bernstein
et al., 2002; Santos-Rosa et al., 2002; Ng et al., 2003;
Schneider et al., 2004; Schubeler et al., 2004; Pokholok
et al., 2005). The histone methyltransferase (HMT) respon-
sible for H3K4me3 modification in yeast, the Set1 com-
plex, is recruited to the 50 end of actively transcribed
genes by interacting with the RNA polymerase II (Pol II)-
associated PAF complex (Miller et al., 2001; Krogan
et al., 2003a; Laribee et al., 2005). Recruitment of mam-
malian homologs of the Set1 complex to promoters
may occur by a similar mechanism (Tenney and Shilati-
fard, 2005). Acetylation of histone H3 lysine 9 and 14
(H3K9,14Ac) also occurs in promoter-associated nucleo-
somes at actively transcribed genes (Liang et al., 2004;
Schubeler et al., 2004; Bernstein et al., 2005; Pokholok
et al., 2005). This is catalyzed by several promoter-associ-
ated histone acetyltransferases (HATs), including Gcn5,
TAF1, and p300/CBP (Sterner and Berger, 2000; Strahl
and Allis, 2000).
Among the modifications associated with transcrip-
tion elongation, the histone H3 lysine 36 trimethyl
(H3K36me3) modification occurs at nucleosomes in the
30 portion of the transcribed region of actively transcribed
genes (Strahl et al., 2002; Bannister et al., 2005; Pokholok
et al., 2005). This may be a consequence of recruitment of
the HMT responsible for this histone modification by the
elongating RNA polymerase (Li et al., 2002, 2003; Xiao
et al., 2003).
The relationship between transcriptional activity and
chromatin state in embryonic stem (ES) cells is ofCell 130, 77–88, July 13, 2007 ª2007 Elsevier Inc. 77
Figure 1. H3K4me3-Modified Nucleo-
somes Are Found at Sites of Transcrip-
tion Initiation
(A) Genomic DNA segments enriched for
H3K4me3-modified histones in hES cells
were identified with ChIP-chip using DNA mi-
croarrays tiling the nonrepeat human genome.
Enrichment ratios for H3K4me3 across 300 kb
of chromosome 21 are shown. Start sites and
direction of transcription are indicated by
arrows.
(B) Composite H3K4me3 enrichment profile for
all known genes. The start site and direction of
transcription of the average gene are indicated
by an arrow. Details of composite profile gener-
ation are described in Supplemental Experi-
mental Procedures.
(C) Fraction of genes enriched for H3K4me3
(enrichment ratio > 2) was calculated for all
known promoters. All genes were aligned
according to the position of their transcription
start sites, and the fraction of genes with
enriched H3K4me3 binding was then calcu-
lated in a sliding 200 bp window.
(D) Single-probe enrichment ratios of
H3K4me3 across the 2.5 kb region surrounding
the transcription start site (10 probes per
promoter). Enriched probes (blue) and unen-
riched probes (white) are shown for each
gene. Individual promoters are represented
top to bottom and are ordered by average
binding ratio within a 1 kb window surrounding
the transcription start site.
(E) H3K4me3 maximum enrichment (blue hori-
zontal line) within 1 kb of the transcription start
site for each gene represented on the whole-
genome array. Genes are ordered as in (D).particular interest. ES cells are uniquely capable of differ-
entiating into almost any cell type (Mayhall et al., 2004;
Pera and Trounson, 2004). ES cell chromatin proteins
have been reported to be in a hyperdynamic state
(Meshorer et al., 2006). Recent studies have shown that
a small set of ES cell genes that are transcriptionally inac-
tive but poised for expression contain histones whose
modifications are characteristic of both active and inactive
genes (Bernstein et al., 2006). However, histone modifica-
tions have yet to be studied throughout the genome of ES
cells.
We report here that the promoter-proximal nucleo-
somes of at least 75% of all protein-coding genes in
human ES cells are trimethylated at histone H3K4. This
is surprising because this particular histone modification
was thought to be associated with only actively tran-
scribed genes. Further study revealed that transcription
initiation and associated histone modifications occur at
most promoters in both ES and differentiated cell types.
Thus, most genes that have been considered inactive
because they produce no detectable transcript nonethe-
less experience transcription initiation. This initiation is
likely responsible for the modified nucleosome landmark
we observe at most promoters.78 Cell 130, 77–88, July 13, 2007 ª2007 Elsevier Inc.RESULTS
Most Promoters in Embryonic Stem Cells Have
Nucleosomes with H3K4me3
We used chromatin immunoprecipitation coupled to
DNA microarray analysis (ChIP-chip) (Boyer et al., 2005;
Lee et al., 2006) to determine how nucleosomes with
H3K4me3 are distributed across the entire genome in
human embryonic stem (hES) cells (Figure 1; see also
the Supplemental Experimental Procedures in the Supple-
mental Data available with this article online). Previous
studies had suggested that H3K4me3-modified nucleo-
somes occur near the transcription start sites of actively
transcribed genes (Bernstein et al., 2002; Santos-Rosa
et al., 2002; Ng et al., 2003; Schneider et al., 2004; Schub-
eler et al., 2004; Pokholok et al., 2005). As expected, we
found H3K4me3 enriched at sites of transcription initiation
(Figure 1A; Table S1). Nearly all sites of H3K4me3 enrich-
ment were within 1 kb of known or predicted transcript
start sites, with maximal enrichment immediately down-
stream of the start site (Figure 1B; Supplemental Experi-
mental Procedures).
Previous studies have estimated that only 30%–45% of
genes have detectable mature transcripts (Sato et al.,
Figure 2. H3K4me3-Modified Nucleo-
somes Are Enriched at Both Active and
Inactive Promoters
(A–F) Genomic DNA segments enriched for
H3K4me3-modified histones were identified
with ChIP-chip using DNA microarrays span-
ning the entire nonrepeat portion of the human
genome. Enrichment ratios are shown for
H3K4me3 at active genes (mRNA transcript
called ‘‘present’’ in Affymetrix expression data
and detected by massively parallel signature
sequencing [MPSS] data) and inactive genes
(mRNA transcript called ‘‘absent’’ in Affymetrix
expression data and not detected by MPSS
data). Gene start and direction of transcription
are indicated by arrows.
(G–I) Composite H3K4me3 enrichment profiles
for genes called present or absent for mRNA
transcript using Affymetrix data (G) (Sato
et al., 2003;Abeyta et al., 2004); genesdetected
or not detected by MPSS (H) (Brandenberger
et al., 2004a; Wei et al., 2005); and genes in
the top 10%, middle 10%, or bottom 10% by
relative expression (I) (Su et al., 2004).2003; Brandenberger et al., 2004a; Su et al., 2004), so we
were surprised to find that 74%of all annotated promoters
were enriched for H3K4 methylation in hES cells at a high
confidence level (Figure 1C; Table S2). Using slightly less
stringent criteria (2-fold enrichment; see Supplemental
Experimental Procedures), we found that 79% of all
protein-coding genes have promoter-proximal nucleo-
somes enriched for H3K4me3 modification (Figures 1D
and 1E; Table S3). This was confirmed using a smaller
array that tiles all known human promoter regions (Sup-
plemental Experimental Procedures; Table S4). These
results led us to believe that a large fraction of genes
for which no transcript has been detected nonetheless
have promoter-proximal nucleosomes enriched for
H3K4me3 modification.
H3K4me3 Is Enriched at Active and Inactive Genes
throughout the Genome
Since H3K4me3 enrichment occurs at a surprisingly large
fraction of known and predicted transcription start sites,
we reexamined how H3K4me3 methylation is related to
transcription. As expected, nucleosomes with H3K4me3
occurred immediately downstream of the transcription
start site of actively transcribed genes (Figures 2A–2C)
(Bernstein et al., 2002; Santos-Rosa et al., 2002; Ng
et al., 2003; Schneider et al., 2004; Schubeler et al.,
2004; Pokholok et al., 2005). Nucleosomes with
H3K4me3 also occurred immediately downstream of thetranscription start site of many genes that are transcrip-
tionally inactive in ES cells. For example, cytokine recep-
tors (IFNAR1), potassium channels expressed in neural
tissue (KCNH1), and genes essential for adipose tissue
function (UCP1) were all found to be occupied by nucleo-
somes modified at H3K4me3 (Figures 2D–2F). Transcripts
for these genes have not been detected in ES cells based
on DNA microarray and massively parallel signature
sequencing (MPSS) data (Sato et al., 2003; Abeyta et al.,
2004; Brandenberger et al., 2004a; Wei et al., 2005). The
signals observed for histone H3K4me3 were typically
lower (about 3-fold) at the inactive genes than at active
genes but were substantially above background and
located at the same position relative to the transcription
start site.
To investigate the relationship between gene transcrip-
tion and H3K4me3 modification genome-wide, we used
three approaches. First, we identified genes whose tran-
scripts in ES cells were consistently called ‘‘present’’ or
‘‘absent’’ in Affymetrix expression data (Sato et al.,
2003; Abeyta et al., 2004) and averaged enrichment
signals for these genes to create composite histone
H3K4me3 profiles for the present and absent genes
(Figure 2G). The composite profiles show that, for both
gene classes, histone H3K4me3 signals span the 3 kb
region surrounding the transcript start site and peak just
downstream of the transcript start site. The level of the
peak signal for H3K4me3 in the absent class of genesCell 130, 77–88, July 13, 2007 ª2007 Elsevier Inc. 79
was about 1/3 of that for the present class. Second, we
identified genes whose transcripts in ES cells were
detected or not detected based on MPSS data (Branden-
berger et al., 2004a; Wei et al., 2005) and created a
composite histone H3K4me3 profile for the two classes
(Figure 2H); the results were very similar to those obtained
with microarray expression data. Finally, we used a
compendium of microarray expression data for 79 differ-
ent human cells and tissues to identify genes whose ES
cell transcript expression levels were in the top 10%,
middle 10%, and bottom 10% relative to all other cells
(Su et al., 2004) and created a composite histone
H3K4me3 profile for the three classes (Figure 2I). The re-
sults confirm that there is a positive correlation between
gene transcript levels and histone H3K4me3 signal yet
show that histone H3K4me3 is observed even at the
promoters of genes for which there is no evidence of tran-
scription in ES cells.
To ensure that the observation that histone H3K4me3
occupies most promoters in human ES cells was not an
experimental or analytical artifact, we conducted a series
of control experiments. A ChIP-chip experiment with
nonspecific IgG produced only background signals that
did not show a general enrichment of promoter regions
(Figure S4; Supplemental Experimental Procedures). A
ChIP-chip experiment with antibody against the transcrip-
tion factor E2F4, with strength of signal comparable to
H3K4me3, showed enrichment of DNA sequences at
<10% of genes (Supplemental Experimental Procedures).
Finally, an experiment with antibody specific for the
histone H3K36me3 modification, which is associated
with transcription elongation, showed enrichment of DNA
sequences well downstream of the transcription start site
at genes that produce RNA transcripts in ES cells (see
below).
Evidence for Transcription Initiation at Most Genes
We considered the possibilities that the presence of
histone H3K4me3 at most promoters is either due to tran-
scription initiation events that occur at many more genes
than suggested by measurements of mature transcripts
or is instead independent of transcription. The former
model predicts that additional histonemodifications asso-
ciated with transcription initiation, as well as the initiating
form of Pol II itself, can be captured at the promoters of
more protein-coding genes than are actively transcribed
based on RNA transcript data (Sato et al., 2003; Branden-
berger et al., 2004b; Su et al., 2004), while the latter would
expect no such correlation.
We carried out ChIP-chip experiments in human ES
cells using arrays tiling 21,223 known transcription start
sites with an antibody specific for H3K9,14Ac, a pair of
histone acetylation modifications associated with tran-
scription initiation (Figures 3A–3E). Acetylation of histone
H3K9,14 is critical for the recruitment of transcription
factor IID (TFIID), an initiating step in transcription (Agalioti
et al., 2002), and should therefore be associated with
genes that have recently initiated transcription. Nucleo-80 Cell 130, 77–88, July 13, 2007 ª2007 Elsevier Inc.somes with histone H3K9,14Ac were enriched at the
promoters of nearly 70% of genes, including both tran-
scriptionally active and inactive genes (Table S2). Nearly
all of the promoters (>95%) acetylated on H3K9 and
H3K14 were also enriched for H3K4me3.
We then carried out ChIP-chip experiments in human
ES cells using an antibody directed against the initiating
form of Pol II (8WG16). The initiating form of Pol II occu-
pied promoters both at genes that produce detectable
transcripts and at genes that do not, albeit at lower levels
(Figures 3F–3J; Table S2). We compared the set of genes
whose promoters were occupied by Pol II with those
occupied by histone H3K4me3. As expected, most pro-
moters (98%) occupied by Pol II were also occupied by
histone H3K4me3, whereas Pol II occupied few genes
(2.3%) that lack histone H3K4me3. The fraction of all pro-
moters enriched for the initiating form of Pol II (52% based
on a 2-fold enrichment ratio) was somewhat smaller than
that occupied by nucleosomes with H3K4me3 modifica-
tion (79%) or by nucleosomes with H3K9,14Ac modifica-
tions (70%). This may be due to greater longevity of the
nucleosome modifications than Pol II at these promoters
or due to the higher signal produced by ChIP with histone
antibodies than ChIP with RNA polymerase antibodies
(Supplemental Results and Discussion). Nevertheless,
our evidence suggests that the majority of genes experi-
ence transcription initiation in human ES cells.
Evidence for Initiation without Transcript
Completion at Many Genes
If the promoters of most genes in human ES cells experi-
ence transcription initiation but only a portion of these
genes produce complete transcripts, then we would
expect to find nucleosome modifications associated
with elongation only at those genes that produce detect-
able transcripts. H3K36me3 modification has been asso-
ciated with elongating Pol II and is enriched within the
body of transcriptionally active genes (Krogan et al.,
2003b; Xiao et al., 2003; Pokholok et al., 2005). Indeed,
we found that H3K36me3 occurs almost exclusively
downstream of promoters that produce detectable tran-
scripts in ES cells (Figures 4A–4C). Additionally, the total
number of genes enriched for H3K36me3 is significantly
lower than the number enriched for modifications associ-
ated with transcription initiation (Figures 4D and 4E).
Histone H3 lysine 79 dimethyl (H3K79me2) modification
has also been shown to be associated with active tran-
scription (Schubeler et al., 2004; Morillon et al., 2005; Po-
kholok et al., 2005). The ChIP-chip results for H3K79me2
were similar to those for H3K36me3 (Figure 4F). Further-
more, we performed ChIP-chip experiments with anti-
bodies that recognize both initiating and elongating Pol II
and found that elongating Pol II signals occur almost
exclusively downstream of promoters that produce
detectable transcripts (Figure 4G). These data suggest
that while transcription initiation occurs at both active
and inactive genes, elongation is strongly correlated only
Figure 3. Enrichment of H3K9,14Ac and Pol II at Inactive Genes
(A and B) Enrichment ratios are shown for H3K9,14Ac, which is associated with initiation. The start site and direction of transcription are indicated by
an arrow.
(C) Composite enrichment profiles for H3K9,14Ac at genes called present or absent for mRNA transcripts using microarray data (as in Figure 2G).
(D) Single-probe enrichment ratios of H3K9,14Ac across the average 2.5 kb region surrounding the transcription start site (10 probes per promoter).
Enriched probes (blue) and unenriched probes (white) are shown for each gene. Individual promoters are represented top to bottom and are ordered
by average binding ratio within 1 kb surrounding the transcription start site (as in Figure 1D).
(E) H3K9,14Ac maximum enrichment (blue horizontal line) within 1 kb of the transcription start site for each gene represented on the human promoter
array. Genes are ordered as in (D).
(F and G) Enrichment ratios are shown for initiating Pol II (antibody 8WG16).
(H) Composite enrichment profiles for initiating Pol II at genes called present or absent for mRNA transcripts using microarray data (as in Figure 2G).
(I) Single-probe enrichment ratios of initiating Pol II across the average 2.5 kb region surrounding the transcription start site (10 probes per
promoter). Enriched probes (blue) and unenriched probes (white) are shown for each gene. Individual promoters are represented top to bottom
and are ordered by average binding ratio within 1 kb surrounding the transcription start site (as in Figure 1D).
(J) Initiating Pol II maximum enrichment (blue horizontal line) within 1 kb of the transcription start site for each gene represented on the human
promoter array. Genes are ordered as in (I).with the set of genes that are active based on transcript
detection.
We tested the possibility that many inactive genes
occupied by histone H3K4me3 actually produce full-
length transcripts that were not detected previously by ei-
ther MPSS or microarray methods (Figures 4H–4I). Using
quantitative RT-PCR, we assayed transcripts for 38 genes
enriched in H3K4me3 but for which transcripts had not
been detected previously (Figure 4H, green bars) and, as
a positive control, 4 genes selected at random from the
list of genes enriched in H3K4me3 for which transcripts
had been previously detected (Figure 4H, blue bars). Stan-
dard curves derived from known quantities of three in-
dependent cDNAs were used to estimate the number
of transcripts per cell (Figure S5). While the randomly
selected positive control genes had transcript levels aver-
aging 69 molecules per cell, the genes in the inactive set
had transcript levels averaging 0.7 molecules per cell.
The levels of transcripts in the positive control groupranged from 2 to 224 molecules per cell, whereas the in-
active set had 0.0002 to 6.5 molecules per cell. These
data show that some of the genes occupied by histone
H3K4me3 and whose transcripts had not been detected
previously by either MPSS or microarray methods are
indeed transcribed, but that little or no transcript accumu-
lates for most of these genes. Interestingly, the levels of
histone H3K4me3, the modification associated with tran-
scription initiation, were similar for the genes in both the
active and inactive classes (Figure 4I). Thus, there is
a class of genes for which there is ample evidence of tran-
scription initiation (promoter occupancy by histone
H3K4me3, histone H3K9,14Ac, and initiating Pol II) but
for which there is little evidence of transcript elongation
(histone H3K36me3, histone H3K79me2, and elongating
Pol II) or transcript accumulation (RT-PCR).
For genes whose promoters were enriched in H3K4me3
but that did not accumulate detectable amounts of mRNA
(Figure 4H), we attempted to detect RNA moleculesCell 130, 77–88, July 13, 2007 ª2007 Elsevier Inc. 81
Figure 4. Events Associated with Transcriptional Elongation Occur at a Minority of Genes
(A andB) Enrichment ratios are shown for H3K36me3, which is associated with elongation. The start site and direction of transcription are indicated by
an arrow.
(C) Composite enrichment profiles for H3K36me3 at genes called present or absent for mRNA transcripts using microarray data (as in Figure 2G). The
start site and direction of transcription of the average gene are indicated by an arrow.
(D) Single-probe enrichment ratios of H3K36me3 across the average 2.5 kb region downstream of the transcription start site (10 probes per
promoter). Enriched probes (blue) and unenriched probes (white) are shown for each gene. Individual genes are represented top to bottom and
are ordered by average binding ratio across the entire region.
(E) H3K36me3maximum enrichment (blue horizontal line) between 1 kb and 3 kb of the transcription start site for each gene represented on the human
promoter array. Genes are ordered as in (D).
(F) Composite enrichment profiles for H3K79me2 at genes called present or absent for mRNA transcripts using microarray data (as in Figure 2G).
(G) Composite enrichment profiles for Pol II (4H8) at genes called present or absent for mRNA transcripts usingmicroarray data (as in Figure 2G). Both
the initiating and elongating forms of Pol II are recognized by this antibody. The area from 1 kb to 3 kb downstream of the promoter (designated e) was
used to determine genes enriched. The start site and direction of transcription of the average gene are indicated by an arrow.
(H) Quantitative RT-PCR analysis of total RNA extracted from hES cells. Estimated transcripts per cell were obtained by dividing the number of
molecules of cDNA, as determined by relative quantitation using the standard curve in Figure S5, by the number of cells used for the amplification.
Positive control probes (active genes, blue bars) and test sample probes (Inactive genes, green bars) are as follows: (1) No probe, (2) RPLPO,
(3) HMGB2, (4) CCNB1, (5) EIF2C3, (6) HOP, (7) GUCY1A3, (8) KITLG, (9) SOX9, (10) PLD1, (11) INCENP, (12) ERCC4, (13) CSF1, (14) HOXB1,
(15) GPR143, (16) DSC3, (17) NFKBIL2, (18) ANG, (19) LEFTY1, (20) LNPEP, (21) TCF21, (22) RAP1GA1, (23) KLF2, (24) KCNJ3, (25) TNFSF7,
(26) PRRG2, (27) FOXG1B, (28) DLX5, (29) KCNH1, (30) ACADL, (31) CXCL2, (32) HOXD12, (33) ONECUT1, (34) LYST, (35) PCSK2, (36) AVPR1B,
(37) SMP3, (38) EPHX2, (39) UCP1, (40) AGC1, (41) ERAF, (42) HBA1, (43)MLNR. Measured values for the genes can be found in Table S6. Broken
axis is indicated by white line.
(I) H3K4me3 maximum enrichment (within 1 kb of the transcription start site) for each gene represented in (H).originating from the extreme 50 end of the gene using real-
time qPCR. We designed probes to sequences within the
50-most 70 nucleotides of genes expressed at <1 tran-
script per cell. The results demonstrate that RNA species
containing sequences at the extreme 50 end can be
detected for essentially all genes tested (Figure S6). We
conclude that many genes that do not produce full-length
mRNAs nonetheless experience transcript initiation.
Genes Not Enriched for H3K4me3 Occur in Clusters
We searched for features common to the genes that
lacked nucleosomes enriched with histone H3K4me3.
Nearly half of the loci lacking histone H3K4me3 con-
tained clusters of R3 homologous genes that encode82 Cell 130, 77–88, July 13, 2007 ª2007 Elsevier Inc.conserved proteins including olfactory receptors, taste
receptors, keratins, apolipoproteins, interleukins, and
leukocyte antigens (Figure 5). In some instances, gene
clusters lacking H3K4me3 enrichment extended across
dozens of genes covering Mb regions of the genome
(Figures 5A and 5B). For example, only 4 of the 309
olfactory genes represented on the DNA microarray
showed >2-fold H3K4me3 enrichment (Table S3). For
these clusters of olfactory receptor genes, there is
evidence that a single enhancer controls selective tran-
scription initiation at a single gene within the cluster
(Lomvardas et al., 2006). It is possible, then, that the
loci containing clustered homologous genes lacking his-
tone H3K4me3 are generally regulated by enhancer
regions that impose stricter control of initiation than
typically observed at other genes.
Transcription Initiation at Inactive Genes
in Differentiated Cells
ES cells possess unique properties, including pluripo-
tency, self-renewal, and hyperdynamic chromatin
(Meshorer andMisteli, 2006). Numerous reports have sug-
gested that silent genes in ES cells are especially poised
to become active upon differentiation (Azuara et al.,
2006; Bernstein et al., 2006; Lee et al., 2006). We therefore
considered the possibility that widespread transcription
Figure 5. Genes Not Enriched for H3K4me3 Are Found in
Clusters along the Genome
(A) Top shows schematic representation of chromosome 1; bottom
shows maximum enrichment ratios of H3K4me3 within 1 kb of the
transcription start site for each gene of chromosome 1. Genes are
shaded blue (H3K4me3 positive) to white (H3K4me3 unenriched).
Large clusters of genes not enriched for H3K4me3 are indicated by
black bars.
(B) Enlarged view of a portion of the 1q23 band of chromosome 1 con-
taining a cluster of olfactory genes devoid of H3K4me3 enrichment.
Ratios for H3K4me3 are shown across 550 kb spanning 11 olfactory
receptors.
(C) Table of H3K4me3 unenriched regions containing at least ten
consecutive genes.initiation at inactive genes is limited to ES cells. To test
this, we profiled histone H3K4me3 modification across
the genome in primary hepatocytes and B cells (Figure 6;
Tables S7 and S8). The results show that the histone
H3K4me3 modification is evident both at genes that
produce detectable transcripts and at those that do not
(Figures 6A and 6C). The promoters of 78% of genes in
hepatocytes and 75% of genes in B cells contain nucleo-
somes with at least a 2-fold enrichment of histone
H3K4me3 (Table S3). We conclude that nucleosomes
with histone H3K4me3 occupy the majority of all active
and repressed genes in both ES cells and differentiated
cells of multiple lineages.
If the presence of nucleosomes with H3K4me3 at the
promoters of inactive genes is associated with transcrip-
tion initiation in these differentiated cells, we would expect
to detect the initiating form of Pol II at many of those
promoters. Indeed, we found that the initiating form of
Pol II is enriched at 42% and 36% of inactive promoters
in B cells and hepatocytes, respectively (Figures 6E–6H).
Cell-Type-Specific Differences in H3K4me3
The majority of all genes contain H3K4me3-modified
nucleosomes in both ES and differentiated cells, but
many promoters do show cell-type-specific differences
in H3K4 trimethylation. The promoters of about 25% of
genes show differential H3K4 methylation in the three
cell types we examined (Figure 7; Supplemental Results
and Discussion). These genes frequently have cell-type-
specific expression patterns and cell-type-specific func-
tion. For example, alcohol dehydrogenase genes do not
contain H3K4me3-modified nucleosomes in either ES
cells or B cells but do contain methylated nucleosomes
in hepatocytes. Only in B cells are the leukocyte receptor
cluster genes occupied by H3K4me3 nucleosomes and
transcribed (Figure 7C). This cell type specificity of H3K4
methylation suggests that transcription initiation is tightly
regulated at this subset of genes and supports our
hypothesis that initiation is tightly regulated at many loci
containing clustered homologous genes (Figure 5).
DISCUSSION
Our results suggest that most protein-coding genes in
human cells, including most genes thought to be tran-
scriptionally inactive, experience the hallmarks of tran-
scription initiation. We found that nucleosomes with
H3K4me3 and H3K9,14Ac modifications, together with
the initiating form of Pol II, occupy the promoters of
approximately 75% of protein-coding genes in human
embryonic stem cells, but only about half of these produce
detectable transcripts. Evidence for transcription initiation
without transcript accumulation was also found for a simi-
lar fraction of genes in hepatocytes and B cells. These
results suggest that protein-coding genes fall into three
groups of regulatory behavior (Figure S7). The actively
transcribed genes are occupied by nucleosomes with
histone modifications that are hallmarks of both initiationCell 130, 77–88, July 13, 2007 ª2007 Elsevier Inc. 83
Figure 6. Enrichment of H3K4me3 at Inactive Genes Occurs in Differentiated Cells
(A, C, E, and G) Composite enrichment profiles for H3K4me3 (A and C) and Pol II (E and G) in primary human hepatocytes (A and E) and the REH line of
pro-B cells (C and G) at genes called present or absent for mRNA transcript using microarray data as in Figure 2G.
(B, D, F, and H) Enriched probe (blue) and unenriched probe (white) profiles for H3K4me3 (B and D) and Pol II (F and H) are shown for each gene in
hepatocytes (B and F) and B cells (D and H). Individual genes are represented top to bottom and are ordered by average binding ratio within 1 kb
surrounding the transcription start site as in Figure 1D.and elongation, and these generally produce detectable
transcripts. A second group experiences transcription
initiation without evidence of transcript elongation or
accumulation. Within this population of genes, which
includes most genes encoding developmental regulators,
regulation of events subsequent to transcription initiation
must play important roles in preventing production or
accumulation of transcripts. The third group consists of
genes that are excluded from experiencing transcription
initiation, where mechanisms that prevent transcription
initiation must predominate.
Previous studies have emphasized that nucleosomes
with histone H3K4me3 are associated with actively
transcribed genes in various eukaryotes (Bernstein et al.,
2002; Santos-Rosa et al., 2002; Ng et al., 2003; Schneider
et al., 2004; Schubeler et al., 2004; Pokholok et al., 2005).
Similarly, histone acetylation has been associated with
actively transcribed genes (Sterner and Berger, 2000).
The genome-wide results from human cells described
here confirm that nucleosomes with H3K4me3 and
H3K9,14Ac are present at actively transcribed genes
and show that the relative levels of these modifications
increase as transcript levels increase (Figure 2; Figure 3;
Figure S6). Among the genes that are actively transcribed
in ES cells based on MPSS and microarray data (Sato
et al., 2003; Abeyta et al., 2004; Brandenberger et al.,
2004a; Wei et al., 2005), 90% contain significantly
enriched levels of H3K4me3 and H3K9,14Ac, with the
highest levels of enrichment found at the promoters of
genes that are most highly expressed (Figure 2I and84 Cell 130, 77–88, July 13, 2007 ª2007 Elsevier Inc.data not shown). Our results also show that nucleosomes
with histone H3K4me3 and H3K9,14Ac occupy promoter
regions, with maximum occupancy just downstream of
the transcription start site (Figure 1; Figure 2; Figure 3;
Figure 6).
A striking result from this study is that among the 55%of
genes that are transcriptionally inactive by either Affyme-
trix or MPSS data in ES cells (Table S5; Sato et al.,
2003; Abeyta et al., 2004; Brandenberger et al., 2004a;
Wei et al., 2005), at least half contain significantly enriched
levels of H3K4me3 and H3K9,14Ac at their promoters
but show no evidence of the elongation-associated
H3K36me3 or H3K79me2 modifications (Table S2). Sev-
eral previous studies have noted the presence of
H3K4me3 at certain inactive genes. Nucleosomes with
H3K4me3 have been reported at inactive genes within
the b-globin locus (Schneider et al., 2004), X-linked genes
(Brinkman et al., 2006), certain transcriptional regulatory
genes (Azuara et al., 2006; Bernstein et al., 2006; Brink-
man et al., 2006), and other genes (Kim et al., 2005).
Because H3K4me3 was assayed at no more than 2% of
all genes in these studies, it was not evident that
occupancy of promoters of transcriptionally inactive
genes by nucleosomes with H3K4me3 is a frequent and
global phenomenon. A recent genome-wide study of
H3K4me3 in T cells did note that 60% of genes were
enriched for H3K4me3 but concluded that the modifica-
tion was associated with actively transcribed genes and
certain classes of genes such as those that are rapidly
inducible (Roh et al., 2006). Our results show that
Figure 7. Tissue-Specific Methylation of
H3K4 at Gene Clusters
(A) Enrichment ratios for H3K4me3 from hES
cells (blue), primary human hepatocytes (red),
and the REH line of pro-B cells (green) across
180 kb of chromosome 7 are shown. Start sites
and direction of transcription are indicated by
arrows.
(B) Enrichment ratios for H3K4me3 from hES
cells (blue), primary human hepatocytes (red),
and the REH line of pro-B cells (green) across
380 kb of chromosome 4 spanning the alcohol
dehydrogenase cluster are shown. ADH1A is
specifically expressed in fetal liver, and ADH7
is expressed in gastric tissue. Constitutively
H3K4me3-modified ADH5 is expressed in all
samples tested.
(C) Enrichment ratios for H3K4me3 from hES
cells (blue), primary human hepatocytes (red),
and the REH line of pro-B cells (green) across
260 kb of chromosome 19 spanning the leuko-
cyte receptor cluster are shown.nucleosomes with H3K4me3 are associated with the pro-
moters of more than half of the transcriptionally inactive
genes in three cell types, that these inactive genes are
not limited to those poised for activation (Table S2;
Supplemental Results and Discussion), and that this
association is likely due to transcription initiation without
transcript accumulation.
The co-occupancy of Pol II with H3K4me3- and
H3K9,14Ac-modified nucleosomes at genes without de-
tectable levels of transcription strongly suggests that
a large fraction of human genes experience transcription
initiation without transcript completion. Indeed, previous
studies have also found Pol II localized to inactive genes
(Soutoglou and Talianidis, 2002; Radonjic et al., 2005).
We do not detect Pol II at all promoters occupied by
H3K4me3 nucleosomes, and although this may simply
be due to less robust signals for Pol II and the noise asso-
ciated with microarray-based methods, it is also possible
that some promoters acquire H3K4me3 nucleosomes in
a manner that does not depend on transcription initiation.
Evidence in budding yeast indicates that H3K4me3
modification occurs subsequent to Pol II recruitment and
Ser5 phosphorylation of the Pol II C-terminal domain (San-
tos-Rosa et al., 2002; Krogan et al., 2003a; Ng et al., 2003;
Pokholok et al., 2005). Similar studies in mammalian cells
show that components of H3K4 methyltransferase com-
plexes interact with the Ser5-phosphorylated form of
Pol II, indicating that transcription initiation coincides with
H3K4me3 deposition (Hughes et al., 2004). Because mul-
tiple H3K4 methylases exist in mammalian cells, it is notclear whether there are multiple mechanisms involved in
their recruitment to promoters, and thus it is possible
that some promoters acquire H3K4me3 nucleosomes in
a manner that does not depend on transcription initiation.
There are at least two general mechanisms that may be
responsible for transcription initiation without transcript
accumulation. In one, the transcription apparatus is
recruited to promoters and initiates transcription but is
prevented from efficient transcript completion. This may
be due to transcriptional pausing, poor processivity, or
abortive initiation, all of which have been described as
mechanisms that prevent initiating polymerase from elon-
gating efficiently through specific genes (Conaway et al.,
2000; Dvir, 2002; Sims et al., 2004; Saunders et al.,
2006). A stable, paused Pol II molecule is found just down-
stream of the transcription initiation site at theHsp70 gene
in Drosophila (Lis, 1998) and it has been estimated that as
many as 20% of Drosophila genes experience some level
of transcriptional pause (Law et al., 1998). Paused RNA
polymerases have also been observed at mammalian
c-Myc, N-myc, and c-Fos promoters (Saunders et al.,
2006). Poorly processive RNA polymerase molecules
can initiate transcription at the HIV long terminal repeat
but do not complete transcription in the absence of the
TAT transcriptional activator (Laspia et al., 1993; Wei
et al., 1998; Parada and Roeder, 1999). Abortive initiation,
which involves premature termination of transcription in
promoter regions, is best understood in prokaryotes but
has also been described in eukaryotes (Dvir, 2002). Tran-
scriptional pausing, poor processivity, or abortiveCell 130, 77–88, July 13, 2007 ª2007 Elsevier Inc. 85
initiation may all contribute to the observations described
here. We do not detect Pol II molecules at all promoters
that are occupied by nucleosomes with histone
H3K4me3, so it is unlikely that a paused Pol II molecule
is stably associated with the promoter regions of all of
these inactive genes. Instead, our evidence is consistent
with a less stable association of Pol II at promoters of
genes that experience transcription initiation without tran-
script accumulation.
A second general mechanism that may be responsible
for transcription initiation without transcript accumulation
is posttranscriptional degradation. It is possible that pre-
mRNA molecules are actually transcribed from the inac-
tive genes but are rapidly degraded or accumulate at
very low levels that are difficult to detect. Some transcripts
may be produced and rapidly degraded as part of the pro-
cess of gene silencing, as has been demonstrated for peri-
centromeric heterochromatin in Schizosaccharomyces
pombe (Kato et al., 2005; Buhler et al., 2006). It is also pos-
sible that some low-abundance transcripts are targeted
for degradation by miRNAs; indeed, mRNA species that
are not detected in specific tissues are more likely to con-
tain target sequences for tissue-specific miRNAs, which
may help control any ‘‘leaky expression’’ (Farh et al.,
2005). If very low levels of transcripts are produced from
the inactive genes, it may be difficult to detect the
mRNA or nucleosomes enriched for H3K36me3. Experi-
ments with genome-wide tiling arrays show evidence for
small amounts of transcript at almost all genes in numer-
ous cell types (Cheng et al., 2005). While we were able
to detect some amount of full-length transcript for almost
all the inactive genes we tested using RT-PCR, the major-
ity of these likely exist at levels much lower than one tran-
script per cell (Figure 4H).
While themajority of genes have promoters enriched for
nucleosomes with histone H3K4me3, one class of genes
provides a notable exception. Clusters of highly related
genes often do not have nucleosomes with H3K4me3
and H3K9,14Ac modifications, nor are they occupied by
the initiating form of Pol II (Figure 5; Figure 7). Many of
the clustered genes lacking H3K4me3 are expressed in
a tissue-specific fashion (Su et al., 2004; Table S3;
Supplemental Results and Discussion). The most numer-
ous members of this class of genes are the olfactory
receptors, in which there is evidence that a single
enhancer controls selective transcription initiation at only
one of many such genes (Lomvardas et al., 2006). The
fact that the clusters of olfactory genes do not experience
transcription initiation and do not contain nucleosomes
enriched in H3K4me3 further supports the view that the
presence of H3K4me3 is a hallmark of transcription initia-
tion at most genes.
In summary, we have found that transcription initiation
and histone H3K4me3 modification occur at the pro-
moters of most protein-coding genes in human cells.
This may serve to create a chromatin structure at tran-
scription initiation sites that is more accessible to tran-
scription factors and signaling kinases than at much of86 Cell 130, 77–88, July 13, 2007 ª2007 Elsevier Inc.the rest of the genome, perhaps providing landmarks
that produce a much smaller search space for these
regulatory molecules. Such landmarks might facilitate
reprogramming of gene expression during differentiation.
EXPERIMENTAL PROCEDURES
Cells and Cell Culture
Human H9 ES cells (WiCell) were cultured as described (Boyer et al.,
2005). Hepatocytes were obtained directly from perfused human liver
at the University of Pittsburgh through the Liver Tissue Procurement
and Distribution System (S. Strom). REH cells (ATCC) were cultured
in RPMI 1640 media containing 10% FBS. Cells were crosslinked as
described (Boyer et al., 2005).
Chromatin Immunoprecipitation and DNA Microarray Analysis
ChIPwas combined with DNAmicroarray analysis as described (Boyer
et al., 2005). The antibodies used here were specific for H3K4me3 (Ab-
cam ab8580), hypophosphorylated RNA polymerase II (8WG16),
H3K9,14Ac (Upstate 06-599), H3K36me3 (Abcam ab9050),
H3K79me2 (Abcam ab3594), total histone H3 (Abcam ab1791), E2F4
(Santa Cruz Biotech sc-1082), and nonspecific IgG (Santa Cruz
Biotech, sc-2043). The design of the oligo-based arrays, which were
manufactured by Agilent Technologies, is described in detail in
Supplemental Experimental Procedures. In addition to simple ratio
measurements mentioned in the text, a whole-chip error model was
used to calculate confidence values from the enrichment ratio and sig-
nal intensity of each probe (probe p value) and of each set of three
neighboring probes (probe-set p value). Probe sets with significant
probe-set p values (p < 0.001) and significant individual probe p values
were judged to be bound at high confidence (see Supplemental Exper-
imental Procedures for additional information). Bound regions were
assigned to an Entrez gene ID if they were within 1 kb of the transcrip-
tion start site from one of four genomic databases, RefSeq, MGC, En-
sembl, or UCSC Known Gene, where the transcript had been assigned
to the Entrez gene (transcript data downloaded from UCSC Genome
Browser, http://genome.ucsc.edu/cgi-bin/hgGateway, using NCBI
build 35). Enrichment ratio plots were expressed as a sliding average
of three neighboring probes.
Gene Expression Analysis
Gene expression data were collated from H1 ES cells (Sato et al.,
2003); H9, HSF1, and HSF6 ES cells (Abeyta et al., 2004); and 79
differentiated human cell and tissue types (Su et al., 2004) and were
analyzed as described in detail in Supplemental Experimental Proce-
dures and in Lee et al. (2006). These data are summarized in Table
S5. Absent/present (AP) calls for hepatocytes and REH cells were
derived from liver and CD19+ peripheral blood samples from Su
et al. (2004).
Quantitative RT-PCR
Standard curves were produced for three independent cDNAs (ANG,
GPR143, and KCNJ3; OriGene Technologies) using 100 ng–0.0001
pg of vector subjected to quantitative real-time PCR in duplicate
(TaqMan predeveloped gene expression assays; Applied Biosystems).
The standard curves were then averaged to produce a composite
standard curve (cycle threshold [Ct] versus molecules present) to
which all test measurements were compared (Figure S5). 6 3
106 hES cells cultured as above were enriched from feeder murine em-
bryonic fibroblasts by trypsinization. RNA was extracted from hES
cells by the TRIzol method and precipitation (Invitrogen). Total RNA
was reverse transcribed by means of the Invitrogen SuperScript III
First-Strand Synthesis System using both oligo(dT) and random hex-
amer primers to produce cDNA. cDNA was amplified using TaqMan
predeveloped gene expression assays as described by the manufac-
turer in an Applied Biosciences 7500 Real-Time PCR Thermocycler in
duplicate. cDNA abundance was determined by measuring the point
during cycling when amplification could first be detected (auto Ct value
determined by Applied Biosciences Prism 7500 software) rather than
the endpoint of the 40-cycle reaction. The measured Ct value was
used to calculate the estimated transcripts present in the test sample
using relative quantitation to the composite standard curve. Genes
determined to be active or inactive by Affymetrix and MPSS methods
were measured using unique TaqMan predeveloped gene expression
assays for each species.
Raw Data
Further information, methods, and raw data can be found at http://
web.wi.mit.edu/young/hES_chromatin/.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
Supplemental Results and Discussion, Supplemental References,
ten figures, and eight tables and can be found with this article online
at http://www.cell.com/cgi/content/full/130/1/77/DC1/.
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